In recent years, scientists have once again begun to study what these powerful medicines can do. In particular, psychedelics like ketamine have been shown to provide substantial relief to people who struggle with major mental health conditions.

Mental Health America estimates that in 2021 57% of adults in America dealing with a mental health disorder did not receive treatment. In other words, over 26 million individuals experiencing mental health conditions were unable to access treatment. Clearly, the need for accessible mental health care in the United States has reached a crisis point.

We’re thrilled to announce that our first peer-reviewed study is now published in Frontiers in Psychiatry: Safety, effectiveness and tolerability of sublingual ketamine in depression and anxiety: A retrospective study of off-label, at-home use.